Daiwa Securities Group Inc. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$12,000
+140.0%
3570.0%0.00%
Q2 2020$5,0000.0%3570.0%0.00%
Q1 2020$5,000
-58.3%
3570.0%0.00%
Q4 2019$12,000
+50.0%
357
-9.6%
0.00%
Q3 2019$8,0000.0%3950.0%0.00%
Q2 2019$8,000
-11.1%
3950.0%0.00%
Q1 2019$9,000
+28.6%
395
+40.6%
0.00%
Q4 2018$7,000
-12.5%
2810.0%0.00%
Q3 2018$8,0000.0%2810.0%0.00%
Q2 2018$8,000
-11.1%
2810.0%0.00%
Q1 2018$9,0002810.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders